Meeting
2020 ASCO Virtual Scientific Program
Socioeconomic disparities in MGMT promoter methylation testing for glioblastoma patients.
Authors
Bryan Iorgulescu
Dana-Farber Cancer Institute, Boston, MA
Bryan Iorgulescu , Nayan Lamba , Timothy R. Smith , David A. Reardon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Access to Care
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7029)
DOI
10.1200/JCO.2020.38.15_suppl.7029
Abstract #
7029
Poster Bd #
301
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Final results of phase 2 trial of personal dendritic cell (DC) vaccines loaded with autologous tumor antigens (ATA) in newly diagnosed glioblastoma (GBM).
First Author: Daniela Annenelie Bota
First Author: Giuseppe Lombardi
Poster
2021 ASCO Annual Meeting
Phase I study of ruxolitinib with radiation and temozolomide in patients with newly diagnosed grade III gliomas and glioblastoma.
First Author: Yasmeen Rauf
Poster
2019 ASCO Annual Meeting
A TITE-CRM phase I/II study of disulfiram and copper with concurrent radiation therapy and temozolomide for newly diagnosed glioblastoma.
First Author: Jiayi Huang